Literature DB >> 12611195

[Social pharmacology: a new topic in clinical pharmacology].

J L Montastruc1.   

Abstract

Social Pharmacology, a new field in Clinical Pharmacology, describes the relationships between Society and Drugs. Topics of Social Pharmacology are first, the social consequences of populations' exposure to drugs and, secondly, the social factors explaining drug use behind clinical or rational explanations. Social Pharmacology also investigates the reasons for prescription, delivery, consumption and self-medication of drugs (behind clinical or rational factors). The paper discusses the role of the different players of Social Pharmacology in the field of drug development, evaluation, prescription and consumption. For example, the pharmaceutical industry should play an important role in the discovery of new medically and socially "desirable" drugs. Drug companies are also involved in this field for drug information to doctors but also patients. Regulatory agencies are concerned by social factors involved in drug approval, regulation of the maximal level of drug use, application and transferability of clinical trials to daily clinical practice. Social Pharmacologists also investigate the factors (others than clinical or rational) regulating drug use. Drug consumption varies according to social characteristics of physicians (sub-speciality, medical education, cultural origin, etc) or patients (gender, age, education, country, kind of work, social status etc). Relationships between drugs and religion make up a large chapter of Social Pharmacology. Other topics in Social Pharmacology involving other health professionals (pharmacists), lawyers and the media are also discussed. Finally, drugs should be considered as important social markers of population behaviour. The role of the Social Pharmacologist is to identify these social and irrational factors governing drug use in order to adapt and rationalize drug utilization in daily clinical practice.

Entities:  

Mesh:

Year:  2002        PMID: 12611195

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  10 in total

1.  Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.

Authors:  V Ozdemir; D Husereau; S Hyland; S Samper; M Z Salleh
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-12

Review 2.  "Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology.

Authors:  T B Ngoundo Mbongue; A Sommet; A Pathak; J L Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2005-05-14       Impact factor: 2.953

3.  Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.

Authors:  G Durrieu; C Hurault; V Bongard; C Damase-Michel; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2007-03-22       Impact factor: 4.335

4.  Bevacizumab versus ranibizumab: why are we not playing the joker?

Authors:  Roberto Banfi; Francesco Attanasio; Nadia Palazzi; Silvia Colombini; Tiziana Falai; Michele Cecchi; Gianni Virgili
Journal:  Int J Clin Pharm       Date:  2013-08

5.  Social Pharmacology and its impact on clinics.

Authors:  Seema Bansal; Saniya Mahendiratta; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2021 Nov-Dec       Impact factor: 1.200

6.  Perception of the risk of gastrointestinal adverse drug reactions with non-steroidal anti-inflammatory drugs (including coxibs): differences among general practitioners, gastroenterologists and rheumatologists.

Authors:  J L Montastuc; V Bongard; M Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2003-10-11       Impact factor: 2.953

7.  Mifepristone in Italy: the case of a drug trapped between ethics and clinical practice.

Authors:  Roberto Banfi; Eleonora Pavone; Rita Cerri; Monica Menichetti
Journal:  Pharm World Sci       Date:  2007-03-07

Review 8.  Social pharmacology: expanding horizons.

Authors:  Rituparna Maiti; José Luis Alloza
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

9.  Is the drug a scientific, social or political object?

Authors:  Régis Bordet
Journal:  Therapie       Date:  2020-05-23       Impact factor: 2.070

10.  COVID-19 vaccines: A perspective from social pharmacology.

Authors:  Jean-Louis Montastruc; Margaux Lafaurie; Claire de Canecaude; François Montastruc; Haleh Bagheri; Geneviève Durrieu; Agnès Sommet
Journal:  Therapie       Date:  2021-05-28       Impact factor: 2.070

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.